中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy

文献类型:期刊论文

作者Feng, Bing1,2,3; Hou, Bo1,2,4; Xu, Zhiai4; Saeed, Madiha1,2; Yu, Haijun1,2,3; Li, Yaping1,2,3
刊名ADVANCED MATERIALS
出版日期2019-08-18
页码10
关键词cancer metastasis chemoimmunotherapy immunogenic cell death immunosuppressive tumor microenvironment self-amplification
ISSN号0935-9648
DOI10.1002/adma.201902960
通讯作者Yu, Haijun(hjyu@simm.ac.cn) ; Li, Yaping(ypli@simm.ac.cn)
英文摘要Chemoimmunotherapy by systemic administration of individual regimens suffers from inconsistent pharmacokinetics profiles, low tumor specificity, and severe side effects. Despite promising nanoparticle-based codelivery approaches in therapeutics, the pathophysiological barriers of solid tumors are a hurdle for tumor accumulation and deep penetration of the drug-loaded nanoparticles. A light-inducible nanocargo (LINC) for immunotherapy is reported. LINC is composed of a reduction-responsive heterodimer of photosensitizer pheophorbide A (PPa) and indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, i.e., NLG919, and a light-activatable prodrug of oxaliplatin (OXA). LINC administrated through intravenous injection is passively accumulated at the tumor site to generate near-infrared (NIR) fluorescence signal. Under fluorescence imaging guidance, the first-wave of NIR laser irradiation induce reactive oxygen species (ROS) generation, trigger cleavage of the polyethylene glycol (PEG) corona, and thus promote tumor retention and deep penetration of LINC. When exposed to the second-wave NIR laser illumination, LINC efficiently elicits the immune response and promotes intratumoral infiltration of cytotoxic T lymphocytes (CTLs). Furthermore, NLG919 delivered by LINC reverses the immunosuppressive tumor microenvironment by suppressing IDO-1 activity. Chemoimmunotherapy with LINC inhibit the tumor growth, lung metastasis, and tumor recurrence. The light-inducible self-amplification strategy for improved drug delivery and immunotherapy shows potential.
WOS关键词IMMUNE CHECKPOINT BLOCKADE ; IMMUNOGENIC CELL-DEATH ; PHOTODYNAMIC THERAPY ; NANOPARTICLES ; OPPORTUNITIES ; INHIBITION ; IDO1
资助项目National Natural Science Foundation of China[31671024] ; National Natural Science Foundation of China[21675055] ; National Natural Science Foundation of China[51873228] ; National Natural Science Foundation of China[81521005] ; Strategic Priority Research Program of CAS[XDA12050307]
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
语种英语
WOS记录号WOS:000481820600001
出版者WILEY-V C H VERLAG GMBH
源URL[http://119.78.100.183/handle/2S10ELR8/288978]  
专题新药研究国家重点实验室
通讯作者Yu, Haijun; Li, Yaping
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.East China Normal Univ, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China
推荐引用方式
GB/T 7714
Feng, Bing,Hou, Bo,Xu, Zhiai,et al. Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy[J]. ADVANCED MATERIALS,2019:10.
APA Feng, Bing,Hou, Bo,Xu, Zhiai,Saeed, Madiha,Yu, Haijun,&Li, Yaping.(2019).Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy.ADVANCED MATERIALS,10.
MLA Feng, Bing,et al."Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy".ADVANCED MATERIALS (2019):10.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。